Plasma proteome signature to predict outcome of breast cancer patients receiving neoadjuvant chemotherapy

ABSTRACT: The purpose of this study is to find candidate biomarkers by analyzing proteins with differential amounts in 17 breast cancer patients’ plasmas with pathological complete response and 34 breast cancer patients’ plasmas without pathological complete response.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Blood Plasma

DISEASE(S): Breast Cancer

SUBMITTER: Kyunggon Kim  

LAB HEAD: Kim Kyunggon

PROVIDER: PXD028251 | Pride | 2022-02-15

REPOSITORIES: Pride